Clinical Pharmacology of Miami ( Site 0003)

Miami, Florida 33172

0 studies enrolling now · 3 studies all time

What they study most

Coronavirus Disease (COVID-19), Hepatic Impairment, Hepatic Impairment (HI)

Studies at this site

• A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015) — Running, not enrolling
• A Study to Evaluate Molnupiravir (MK-4482) in Participants With Moderate Hepatic Impairment (MK-4482-016) — Completed
• Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) — Stopped early